® Consulta de Marcas Base do INPI · pesquisa e monitoramento

RHEACELL Innovative Stem Cell Therapies

Aguardando apresentação ou exame de recurso contra o indeferimento de Designação Recebida

Marca Nominativa depositada no INPI em 15/12/2023 por RHEACELL GmbH & Co. KG, processo nº 501581960, nas classes 05, 42, 44. O processo não está mais ativo — o nome pode estar livre para novo pedido.

Número do processo501581960
SituaçãoAguardando apresentação ou exame de recurso contra o indeferimento de Designação Recebida
ApresentaçãoNominativa
NaturezaMadri Produto/Serviço
Data do depósito15/12/2023
Data da concessão—
Vigência até11/12/2030
TitularRHEACELL GmbH & Co. KG
UF · País— · DE

Classes e especificação

Classe 05 — Farmacêuticos e saúde

Drugs; pharmaceutical and veterinary preparations; diagnostic agents; pharmaceutical preparations; preparations for medical purposes; preparations for biomedical purposes; pharmaceutical cell preparations for medical use; substances for medical use; substances for biomedical purposes; live implants for pharmaceutical purposes; biochemical and chemical products for medical use; biochemical and chemical products for pharmaceutical purposes; biochemical and chemical products for diagnostic purposes; proteins for medical purposes; biological preparations for medical and veterinary purposes, and pharmaceutical and veterinary preparations, all for external use; biological, pharmaceutical and veterinary preparations for skin care for medical purposes; medical dressings; preparations for wound treating and healing; biological, pharmaceutical and veterinary preparations for the treatment of chronic wounds, ulcers, burns and surgical wounds; stem cells for medical purposes; stern cells for veterinary purposes; stern cells for aesthetic purposes; somatic stem cell therapeutics; fibroblasts for medical purposes; fibroblasts for aesthetic purposes; pharmaceutical implants; surgical implants derived from stem cells; surgical implants derived from fibroblasts; biological tissue for implantation; growth media for culturing cells for medical purposes; pharmaceutical preparations for tissue regeneration; vascular grafts; living tissue; biotechnologically engineered tissue products.;

Classe 42 — Tecnologia e pesquisa

Pharmaceutical drug development; scientific and technological services; research and development services in the fields of cell diagnostics and therapy and surgical and medical instruments; industrial analysis and research services; scientific research for medical purposes; stem cell research; scientific and medical research and development; scientific research, testing and analysis services; scientific research for medical purposes; medical research; research in the field of biotechnology; research in the field of gene therapy; research and development in the field of immunology; research and development in the field of antibodies; research and development in the field of antibody technology; research and development in the field of bacteriology; research and development in the field of gene expression systems; research and development in the field of vaccines; research and development services for the pharmaceutical industry research and development services in the field of biotechnology.;

Classe 44 — Saúde e beleza

Medical services; medical diagnostic services {carrying out tests and analyses]; medical assistance; clinic services; hospital services; plastic and cosmetic surgery; medical therapies; medical services relating to the removal, treatment, processing and storage of human cells and tissue, stem cells and bone marrow, also in the field of regenerative medicine, including tissue engineering; medical services in connection with the removal, treatment, processing and storage of human tissue and stem cells, also in the field of regenerative medicine, including tissue engineering; medical services relating to the cultivation and procurement of stem cells; medical services in connection with the cultivation and procurement of stem cells.;

Acompanhe este processo

Receba um e-mail a cada novo despacho publicado na RPI para o processo 501581960 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.

Monitorar esta marca Ver marcas parecidas

Andamento do processo no INPI

2 despacho(s) publicado(s) na Revista da Propriedade Industrial.

  1. 10/06/2025 Indeferimento de designação <b>Detalhes do despacho: </b>A marca reproduz ou imita os seguintes registros de terceiros, sendo, portanto, irregistrável de acordo com o inciso XIX do Art. 124 da LPI. As anterioridades impeditivas identificadas na busca realizada em cada classe do pedido são as seguintes: NCL(11-0)5: Processo 909371482 (RECELL), NCL(11-0)42: Processo 902487795 (Rhea Biotech), Processo 840315244 (RECELL) e NCL(11-0)44: Processo 840315260 (RECELL). Art. 124 - Não são registráveis como marca: XIX - reprodução ou imitação, no todo ou em parte, ainda que com acréscimo, de marca alheia registrada, para distinguir ou certificar produto ou serviço idêntico, semelhante ou afim, suscetível de causar confusão ou associação com marca alheia; código IPAS774 · RPI 2840
  2. 30/07/2024 Publicação de pedido de registro para oposição (exame formal de designação concluído) código IPAS756 · RPI 2795